You do not want another report calling your labs normal while you still wonder what your results are missing. A biological age test estimates an aging-related pattern, not your true age or remaining lifespan. For decisions about your health, physician-interpreted blood biomarkers give you a more direct place to start.

Key Takeaways
  • A biological age test estimates an aging-related pattern and cannot establish your remaining lifespan.
  • GoodLife Health prioritizes actionable blood biomarkers through Cardiometabolic Optimization, not a promised younger age score.
  • Blood-based clocks, DNA methylation tests and telomere tests measure different things and are not interchangeable.
  • Choose clinical interpretation and follow-up before paying for another longevity testing dashboard.

Why this matters: you want an explanation, not another number

Being told that nothing is wrong does not resolve persistent fatigue, changing body composition or concern about a family history of diabetes or heart disease. The fear is not simply getting older. It is spending more time collecting reassuring numbers while a treatable condition or meaningful risk goes unaddressed.

The better outcome is specific: understand which findings matter, what deserves treatment and how your physician will check whether the plan works. Our GoodLife Health approach to Cardiometabolic Optimization treats metabolic, hormonal and cardiovascular health as one connected system rather than translating everything into a birthday.

That distinction also changes what you pay for. Instead of buying a report and then arranging separate interpretation and follow-up, our $299/month membership includes direct primary care and a Biomarker Audit every 90 days. The $598 covering the first two months is held on your card at sign-up and charged only once the clinician accepts you. If the clinician cannot accept you, the hold is released and you are never charged. Once accepted, the first two months are non-refundable, then it is $299/month with cancellation anytime after that.

Medication is separate and billed by the pharmacy you choose at that pharmacy's own price, with no molecule or dose upcharge on the membership fee. Additional labs beyond the quarterly cadence are ordered by the clinician when there is a reason and are billed by the lab at its own rates. The membership fee does not increase with your prescription, although your pharmacy bill is a separate expense.

GoodLife Health is best for adults who want ongoing Cardiometabolic Optimization rather than a standalone biological age score. That is a recommendation about the care model, not a claim that our membership measures biological age or proves that aging has reversed.

What the numbers show
$299/mo
Cardiometabolic Optimization Membership fee
$598
Held at sign-up for the first two months, charged only once the clinician accepts you
90 days
Biomarker Audit frequency (4 per year)
3 months
Average glucose window reflected by HbA1c

What makes the best biological age test approach?

For this 2026 guide, we rank testing approaches by what they help you do, not by how dramatic the final number looks.

  • Clinical actionability: Does a finding inform an established prevention, diagnostic or treatment decision?
  • Measurement clarity: Does the report distinguish what the laboratory measures from what an algorithm estimates?
  • Relevant validation: Was the model evaluated for the outcome it claims to predict, in a population relevant to you?
  • Repeatability: Can you compare results under similar collection conditions using the same method?
  • Interpretation: Does a physician connect the findings with symptoms, medications, examination and family history?
  • Follow-through: Is someone responsible for acting on an abnormal result and reviewing the response?

An impressive association with population-level outcomes does not automatically make a test useful for choosing an individual treatment. Ask what changes if the result comes back older, younger or unchanged. A clear answer matters more than a colorful dashboard.

Biological age testing approaches at a glance

The table compares approaches, not interchangeable products. Our Biomarker Audit belongs first for clinical follow-through, but it is not presented as a proprietary aging clock.

Biological age testing approaches

Compared by clinical actionability, not drama of the score

ApproachBest forStandout featureKey limitation
GoodLife Health Biomarker AuditOngoing clinical managementQuarterly biomarkers connected to direct primary careDoes not establish a biological age or lifespan
Blood-based phenotypic age estimateUnderstanding a blood-derived aging modelCombines routine measurements into an age-like estimateOutput depends on the model and its inputs
DNA methylation clockExploring epigenetic aging estimatesEvaluates methylation patterns associated with aging-related outcomesClock changes do not prove longer life
Telomere length testUnderstanding a specific cellular measurementMeasures chromosome-end length in the sampled materialCannot summarize whole-body aging
GoodLife Health. Medicine that builds on itself, $299 a month: 90-day labs, your clinician, branded GLP-1s, one platform. See if you qualify.GoodLife Health. $299 a month. Everything talks to everything: quarterly labs read by your clinician, branded GLP-1s prescribed from them, every result and dose tracked on one platform. See if you qualify.

1. Biomarker Audit: best for turning bloodwork into a care plan

Our Biomarker Audit examines cardiometabolic health through measurements including Apolipoprotein B (ApoB), Lipoprotein (A), Hs-CRP, Hemoglobin A1c (HbA1c), Lipid Panel, Standard, Fasting Insulin and more. The purpose is to connect findings with care, not issue an age certificate. Symptoms, medical history and medication use remain part of the interpretation.

The membership includes an audit every 90 days or four per year, through Quest Diagnostics. Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation, under our clinical protocols. Those physicians are not our employees.

Clinical note

Clinical care is delivered by licensed physicians of Beluga Health, P.A., an independent Florida professional corporation, under our clinical protocols. Those physicians are not our employees.

Biomarker Audit pros:

  • Connects laboratory findings with physician-led assessment.
  • Reviews metabolic, hormonal and cardiovascular health together.
  • Includes scheduled repeat testing rather than a standalone report.
  • Separates the physician membership fee from pharmacy billing.

Biomarker Audit limitations:

  • Does not measure a single, definitive biological age.
  • Does not replace physical examination, imaging or specialist evaluation when indicated.
  • Quarterly testing is the membership cadence, not a universal medical requirement for every marker.

Best for: Adults who want a clinician to translate findings into an ongoing prevention or treatment plan.

Verdict: Buy the care relationship when your goal is clinical action, not an age estimate.

2. Blood-based phenotypic age: best for exploring routine-lab models

Blood-based phenotypic age models combine selected laboratory measurements, sometimes alongside chronological age, into an estimate related to aging or health risk. PhenoAge is a published example. A commercial report using similar language is not automatically using the same formula or validation.

These models summarize selected information. They do not directly measure every organ's condition and their inputs differ from a clinical cardiometabolic panel. A model without ApoB, for example, does not answer the same question as an ApoB measurement.

Blood-based phenotypic age pros:

  • Makes the relationship between routine bloodwork and aging research easier to explore.
  • Can use familiar clinical measurements, depending on the model.
  • Offers an opportunity to inspect the underlying inputs rather than only the final score.

Blood-based phenotypic age limitations:

  • Different formulas produce different estimates from overlapping information.
  • Temporary changes in input markers can influence the result.
  • A lower score does not establish that an intervention extends your life.

Best for: People who want to understand a transparent blood-derived aging model alongside clinical care.

Verdict: Buy only as an optional interpretive layer, not as a replacement for reviewing individual biomarkers.

3. DNA methylation clocks: best for epigenetic aging questions

DNA methylation clocks analyze chemical marks on DNA and apply an algorithm to estimate an aging-related characteristic. Different clocks were developed for different targets, including chronological age, mortality-related patterns or pace of aging. Those outputs are not equivalent.

Sample type and analytical method also matter. A result from one clock should not be treated as directly interchangeable with a result from another, even when both display an age in years.

DNA methylation clock pros:

  • Measures molecular information distinct from a standard chemistry panel.
  • Connects with an established field of aging research.
  • Provides a defined model output when the laboratory identifies the clock used.

DNA methylation clock limitations:

  • Does not diagnose the cause of fatigue, weight change or hormone symptoms.
  • Does not independently determine which medication you need.
  • A change after an intervention is not proof of reduced disease events or longer survival.

Best for: People interested in epigenetic aging research who understand the uncertainty around individual interpretation.

Verdict: Buy for an informed research interest, not to choose treatment or certify rejuvenation.

4. Telomere length: best for a narrow cellular question

Telomeres are protective structures at chromosome ends. A telomere length test measures that feature in the sampled cells, rather than directly measuring the age of your entire body. Interpretation depends on the method, sample and clinical setting.

Telomere testing has specialized medical applications in the evaluation of suspected telomere biology disorders. That use is different from marketing a general wellness result as a complete aging assessment.

Telomere length test pros:

  • Examines a defined biological feature rather than a vague wellness concept.
  • Has a role in selected specialist evaluations.
  • Illustrates one mechanism studied in aging biology.

Telomere length test limitations:

  • Does not capture the full set of processes involved in aging.
  • Cannot reliably turn an individual result into remaining years of life.
  • Is not a substitute for assessing blood pressure, glucose, lipids or symptoms.

Best for: A specific question discussed with a qualified clinician, particularly when specialist evaluation is indicated.

Verdict: Skip as your default longevity purchase. Use it when there is a defined clinical or research purpose.

What blood biomarkers can measure in 2026

Blood biomarkers measure particular substances, cell characteristics or physiological signals. Their clinical value comes from answering defined questions. They become less useful when every result is stretched into a claim about aging.

Lipid risk

ApoB helps assess the concentration of atherogenic lipoprotein particles. Lp(a) identifies a largely inherited contributor to cardiovascular risk, while a standard lipid panel supplies related cholesterol and triglyceride information. These findings belong beside blood pressure, smoking history, diabetes status and family history.

A favorable biological age score does not cancel an unfavorable cardiovascular risk assessment. The treatment discussion should address the risk itself, not whether the dashboard gives you a younger number.

Glucose regulation

HbA1c reflects average blood glucose over approximately 3 months. Fasting glucose measures blood glucose at collection, while insulin measurements address a different part of glucose regulation. Interpretation depends on the clinical question and relevant limitations of each assay.

These measurements can inform evaluation and management of dysglycemia. They do not identify a universal metabolic age and an isolated insulin result does not replace a clinical assessment.

Inflammation

High-sensitivity C-reactive protein or hs-CRP, measures an inflammatory signal. Infection, injury and other conditions can affect it, so an unexpected result needs context before it becomes a long-term conclusion.

Lower is not automatically evidence of younger tissue. The useful question is whether the result reflects a temporary event, persistent inflammation or a finding relevant to cardiovascular risk assessment.

Hormone context

Thyroid and sex-hormone testing can help investigate symptoms when interpreted with timing, reproductive stage, medications and history. A result outside a reference range does not automatically establish a diagnosis and a result inside the range does not explain every symptom.

Hormone treatment is not a way to chase a younger age score. It requires an appropriate indication, a discussion of benefits and risks and follow-up based on the treatment involved.

Four biomarker domains connected to a central clinical assessment

Individual biomarkers answer different questions. Clinical assessment connects them.

What a biological age test cannot tell you

No single biological age test establishes the true age of every tissue in your body. Aging involves multiple processes and a sample captures selected information through a particular method. Converting that information into years does not remove the model's assumptions.

An age estimate also cannot tell you when you will die, rule out cancer or replace recommended preventive screening. It cannot explain every symptom. Chest pain, severe shortness of breath or stroke symptoms need emergency evaluation, regardless of what a longevity report says.

The distinction between prediction and treatment is especially important. A model can be associated with future outcomes without being a proven treatment target. Changing its output is not automatically the same as changing the outcome it predicts.

That is the central limit to remember in 2026: a younger estimate is a model result, not proof that you have added years to your life. Evaluate the underlying clinical changes separately.

A younger estimate is a model result, not proof that you have added years to your life.

Why a better score is not the same as better diabetes care

For someone managing diabetes, the important questions concern glucose patterns, medication effects, hypoglycemia, kidney health and cardiovascular risk. An aging score cannot replace those decisions. Even a favorable trend needs interpretation alongside the underlying measurements.

The collection setting does not change that responsibility: blood tests for diabetes monitoring still need appropriate sample handling, clinician interpretation and follow-through on abnormal findings, whether collected at home or in a laboratory.

HbA1c also has limitations. Conditions that affect red blood cells or hemoglobin can make the result less representative of average glucose, which is why discordant findings deserve review rather than automatic reassurance.

Clinical note

HbA1c also has limitations. Conditions that affect red blood cells or hemoglobin can make the result less representative of average glucose, which is why discordant findings deserve review rather than automatic reassurance.

Ask your physician what improvement means for your specific condition. A useful answer names the measurement, its limitations, the intended treatment effect and the next review. It does not stop at a lower biological age.

How to compare results without fooling yourself

A repeat result is meaningful only when you understand what changed in the measurement and what changed in you. Before interpreting a trend, confirm that the laboratory, units, assay and age-estimation method are comparable. Keep the underlying report, not just a screenshot of the headline score.

Keep conditions comparable

Follow the ordering clinician's instructions about fasting, collection timing and medication timing. Do not stop prescribed medication or supplements on your own to improve a test result. Report recent illness, major training changes and other circumstances relevant to interpretation.

Separate signal from variation

Measurements fluctuate and derived scores inherit variation from their inputs. If an unexpected result would change treatment, ask whether it needs confirmation and what would explain disagreement with earlier findings. More frequent testing is not automatically more informative.

Choose the endpoint first

Before treatment starts, agree on what success means. That might include improved glucose control, reduced atherogenic particle burden, symptom relief or better blood pressure management, depending on your situation. An age score should not displace the endpoint that justified treatment.

For your 2026 records, preserve the test name, method, collection date, actual values and clinical interpretation together. That makes the next comparison more useful than a folder of unrelated longevity summaries.

Turn testing into a clinical plan

A useful testing process starts before the blood draw. Bring your symptoms, family history, prior results, prescriptions and supplements into the discussion so your physician can decide which questions need answering. Ordering everything is not the same as investigating carefully.

  1. Define the question. Distinguish curiosity about aging from a concern about fatigue, glucose regulation, cardiovascular risk or another symptom.
  2. Choose the measurements. Ask which tests address that question and what each result would change.
  3. Interpret the pattern. Review findings together rather than treating every flagged value as an independent disease.
  4. Agree on action. Document the next step, whether that is lifestyle support, further evaluation, medication or confirmation.
  5. Review the response. Use a follow-up interval appropriate to the problem rather than repeatedly checking for a younger score.

Our Cardiometabolic Optimization Membership supplies that ongoing clinical structure, with the included Biomarker Audit every 90 days. It does not mean every marker needs intervention or that every normal result needs to be pushed toward a different target.

For eligible patients, treatment can include branded, FDA-approved GLP-1 medication or hormone optimization when clinically indicated. Neither is prescribed merely because an aging algorithm reports an older estimate. Nutrition, physical activity, sleep, medication safety and appropriate preventive care remain part of the discussion.

Review the membership pricing and take the next step toward a clinical assessment. The decision is whether you want ongoing care built around actionable findings, not whether a dashboard can make you feel younger.

How we ranked these approaches

This ranking prioritizes clinical actionability, clear measurement, interpretation and follow-through. It is not a head-to-head laboratory accuracy study and it does not establish that one aging clock predicts every outcome better than another.

The Biomarker Audit ranks first for the reader seeking care because it connects measurements with a physician relationship. Blood-derived models and methylation clocks answer different research-oriented questions. Telomere length is narrower still. None should be judged solely by how many years the report subtracts.

Which approach should you choose in 2026?

Choose physician-led biomarker assessment first when your goal is better health decisions. Add a biological age estimate only when you understand its method, limitations and purpose. That keeps the estimate in its proper place: supplementary information rather than a diagnosis or treatment target.

GoodLife Health connects Cardiometabolic Optimization with quarterly testing, direct primary care and pharmacy billing without medication markup. The advantage is the structure around the result: someone evaluates what matters and follows the response. A number alone cannot provide that relationship.

FAQ

What does a biological age test actually measure?

A biological age test measures selected biological features and applies a model to estimate an aging-related characteristic. Blood-based models, DNA methylation clocks, and telomere tests use different information, so their results are not interchangeable.

References

  1. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). 2022. pubmed.ncbi.nlm.nih.gov/35658024/
  2. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). 2021. pubmed.ncbi.nlm.nih.gov/33567185/